374 related articles for article (PubMed ID: 6209513)
1. High-dose intravenous gammaglobulin for Kawasaki disease.
Furusho K; Kamiya T; Nakano H; Kiyosawa N; Shinomiya K; Hayashidera T; Tamura T; Hirose O; Manabe Y; Yokoyama T
Lancet; 1984 Nov; 2(8411):1055-8. PubMed ID: 6209513
[TBL] [Abstract][Full Text] [Related]
2. High-dose gammaglobulin therapy for Kawasaki disease.
Nagashima M; Matsushima M; Matsuoka H; Ogawa A; Okumura N
J Pediatr; 1987 May; 110(5):710-2. PubMed ID: 2437278
[TBL] [Abstract][Full Text] [Related]
3. [Study on coronary artery lesions in patients with Kawasaki disease: recent 9 years' experience].
Wu JR; Hwang KP; Tu JG; Dai ZK; Huang TY
Gaoxiong Yi Xue Ke Xue Za Zhi; 1993 Jan; 9(1):27-38. PubMed ID: 7682261
[TBL] [Abstract][Full Text] [Related]
4. Selective high dose gamma-globulin treatment in Kawasaki disease: assessment of clinical aspects and cost effectiveness.
Sato N; Sugimura T; Akagi T; Yamakawa R; Hashino K; Eto G; Iemura M; Ishii M; Kato H
Pediatr Int; 1999 Feb; 41(1):1-7. PubMed ID: 10200128
[TBL] [Abstract][Full Text] [Related]
5. Overview of pharmacological treatment of Kawasaki disease.
Onouchi Z; Kawasaki T
Drugs; 1999 Nov; 58(5):813-22. PubMed ID: 10595862
[TBL] [Abstract][Full Text] [Related]
6. The treatment of Kawasaki syndrome with intravenous gamma globulin.
Newburger JW; Takahashi M; Burns JC; Beiser AS; Chung KJ; Duffy CE; Glode MP; Mason WH; Reddy V; Sanders SP
N Engl J Med; 1986 Aug; 315(6):341-7. PubMed ID: 2426590
[TBL] [Abstract][Full Text] [Related]
7. Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin.
Leung DY; Burns JC; Newburger JW; Geha RS
J Clin Invest; 1987 Feb; 79(2):468-72. PubMed ID: 2433307
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose.
Terai M; Shulman ST
J Pediatr; 1997 Dec; 131(6):888-93. PubMed ID: 9427895
[TBL] [Abstract][Full Text] [Related]
9. Management of Kawasaki disease in the British Isles.
Dhillon R; Newton L; Rudd PT; Hall SM
Arch Dis Child; 1993 Dec; 69(6):631-6; discussion 637-8. PubMed ID: 8285773
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of plasmin-treated intravenous gamma-globulin for therapy of Kawasaki syndrome.
Hsu CH; Chen MR; Hwang FY; Kao HA; Hung HY; Hsu CH
Pediatr Infect Dis J; 1993 Jun; 12(6):509-12. PubMed ID: 8345983
[TBL] [Abstract][Full Text] [Related]
11. Coronary risk factors in Kawasaki disease treated with additional gammaglobulin.
Miura M; Ohki H; Tsuchihashi T; Yamagishi H; Katada Y; Yamada K; Yamashita Y; Sugaya A; Komiyama O; Shiro H
Arch Dis Child; 2004 Aug; 89(8):776-80. PubMed ID: 15269082
[TBL] [Abstract][Full Text] [Related]
12. Reduction of peripheral blood macrophages/monocytes in Kawasaki disease by intravenous gammaglobulin.
Furukawa S; Matsubara T; Jujoh K; Sasai K; Nakachi S; Sugawara T; Yabuta K; Kato H
Eur J Pediatr; 1990 Nov; 150(1):43-7. PubMed ID: 1706665
[TBL] [Abstract][Full Text] [Related]
13. Intravenous gamma-globulin for Kawasaki disease.
Furusho K; Kamiya T; Nakano H; Kiyosawa N; Shinomiya K; Hayashidera T; Tamura T; Hirose O; Manabe Y; Yokoyama T
Acta Paediatr Jpn; 1991 Dec; 33(6):799-804. PubMed ID: 1801560
[TBL] [Abstract][Full Text] [Related]
14. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
Mori M; Imagawa T; Yasui K; Kanaya A; Yokota S
J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408
[TBL] [Abstract][Full Text] [Related]
15. [Clinical manifestations and effects of IVGG in patients with Kawasaki disease].
Hwang KP; Wu JR; Huang LY; Liou CC; Huang TY
Kaohsiung J Med Sci; 1996 Mar; 12(3):159-66. PubMed ID: 8709183
[TBL] [Abstract][Full Text] [Related]
16. Intravenous gammaglobulin and reduction of coronary artery abnormalities in children with Kawasaki Disease.
Nishihara S; Ishibashi K; Iribe K; Matsuda I
Lancet; 1988 Oct; 2(8617):973. PubMed ID: 2459575
[No Abstract] [Full Text] [Related]
17. Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease.
Furukawa S; Matsubara T; Umezawa Y; Motohashi T; Ino T; Yabuta K
Eur J Pediatr; 1994 Sep; 153(9):663-7. PubMed ID: 7957426
[TBL] [Abstract][Full Text] [Related]
18. Kawasaki syndrome in 18 children in the west of Scotland.
Odaibo FS; Goel KM
Scott Med J; 1991 Aug; 36(4):107-9. PubMed ID: 1720900
[TBL] [Abstract][Full Text] [Related]
19. New hope for children with Kawasaki disease.
Lux KM
J Pediatr Nurs; 1991 Jun; 6(3):159-65. PubMed ID: 1710660
[TBL] [Abstract][Full Text] [Related]
20. Histopathologic and coronary angiographic assessment of effectiveness of aspirin or aspirin-and-gammaglobulin in Kawasaki disease.
Haneda N; Mori C
Acta Paediatr Jpn; 1993 Aug; 35(4):294-7. PubMed ID: 7691025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
